Search results
Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
Zacks via Yahoo Finance Canada· 7 days agoEli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be...
FDA approves Kisunla for early Alzheimer's treatment amid cognitive decline slowdown
BioPharma-Reporter· 6 days agoIn the TRAILBLAZER-ALZ 2 phase 3 study, which included 1736 participants with early symptoms of ...